Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
q7d × 3) modulates Lymph node cells (LNC) responses
Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strategy in ovarian cancer
It has ~28-fold greater selectivity over UCH-L3 (ubiquitin C-terminal hydrolase L3)
Salidroside can improve muscle nutrition via increasing mTOR
C[C@H](N[C@@H](CCC1C=CC=CC=1)C(=O)OCC)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O
SB 415286 Catalog No.:M10079-2 q7d × 3) modulates LymphSB 415286 is a potent and selective cell permeable, ATP competitive inhibitor of GSK3 with an IC50 value of 78 nM (similar potency for GSK3) and a Ki value of 31 nM. Pharmacological GSK 3 inhibitors are potential drugs for the treatment of neurodegenerative diseases, cancer and diabetes. Product information CAS Number: 264218 23 7 Molecular Weight: 359. 72 Formula: C16H10ClN3O5 Chemical Name: 3 [(3 chloro 4 hydroxyphenyl)amino] 4 (2 nitrophenyl) 2,5
US$ 129.00
US$ 69.00
US$ 12.42
US$ 149.00
US$ 199.50
US$ 79.00
US$ 199.00
US$ 139.00